Table 1.
Association between potential risk factors and HSV detected in CVL
| Cofactors | Present | Absent | Relative risk (95% CI) | P-value |
| GUD | 2/5 (40%) | 25/65 (38%) | 1.04 (0.34 – 3.18) | 0.68 |
| Anti HSV-2 IgG* (Kalon test) | 11/27 (41%) | 7/32 (22%) | 1.86 (0.84 – 4.13) | 0.19 |
| HIV | 3/7 (43%) | 23/59 (39%) | 1.1 (0.44 – 2.74) | 0.83 |
| BV | 14/35 (40%) | 13/35 (37%) | 1.08 (0.60 – 1.95) | 1.00 |
| C. trachomatis | 5/7 (71%) | 22/63 (35%) | 2.05 (1.15 – 3.64) | 0.14 |
| Hepatitis B | 5/8 (63%) | 22/54 (41%) | 1.53 (0.82 – 2.87) | 0.44 |
| Candida | 9/29 (31%) | 18/41 (44%) | 0.71 (0.37 – 1.35) | 0.40 |
| T. vaginalis | 3/7 (43%) | 24/63 (38%) | 1.13 (0.45 – 2.80) | 0.86 |
* Comparison with HSV-2 only. P values calculated by χ2 test